CHEOF (Cochlear) Total Liabilities: $569 Mil (As of Dec. 2025)


CHEOF Cochlear Ltd CHEOF
62 GF Score
Price $81.42
GF Value $210.35
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Cochlear Total Liabilities?

Cochlear CHEOF 62 Total Liabilities is $569 Mil as of Dec. 2025. GuruFocus rates CHEOF with a GF Score™ of 62/100 and a GF Value™ of $210.35 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Cochlear's Total Liabilities for the quarter that ended in Dec. 2025 was $569 Mil.

Cochlear's quarterly Total Liabilities declined from Dec. 2024 ($581.70 Mil) to Jun. 2025 ($569.47 Mil) and declined from Jun. 2025 ($569.47 Mil) to Dec. 2025 ($568.51 Mil).

Cochlear's annual Total Liabilities increased from Jun. 2023 ($550.27 Mil) to Jun. 2024 ($600.66 Mil) but then declined from Jun. 2024 ($600.66 Mil) to Jun. 2025 ($569.47 Mil).

Cochlear Total Liabilities Historical Data

* Premium members only.

The historical data trend for Cochlear's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cochlear Total Liabilities Chart

Cochlear Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 563.07 547.72 550.27 600.66 569.47

Cochlear Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 501.14 600.66 581.70 569.47 568.51
CHEOF
62GF Score
Cochlear Ltd CHEOF
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cochlear Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Cochlear's Total Liabilities for the fiscal year that ended in Jun. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=392.122+(125.977+29.753
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+13.997+7.617+0)
=569

Total Liabilities=Total Assets (A: Jun. 2025 )-Total Equity (A: Jun. 2025 )
=1839.193-1269.727
=569

Cochlear's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=371.362+(132.89+53.157
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+11.096+0+0)
=569

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=1856.279-1287.774
=569

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $569 Mil mean?
Cochlear (CHEOF) has a Total Liabilities of $569 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Cochlear and its competitors.
Is Cochlear's Total Liabilities too high?
Cochlear's current Total Liabilities is $569 Mil. Overall, Cochlear has a GF Score™ of 62/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cochlear's Total Liabilities compare to ABT and SYK?
Cochlear's Total Liabilities of $569 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Devices & Instruments company?
A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Cochlear and its competitors. Cochlear's current Total Liabilities is $569 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cochlear stock overvalued right now?
Based on GuruFocus' analysis, Cochlear (CHEOF) is currently considered Significantly Undervalued. The stock's GF Value™ is $210.35, compared to a current price of $81.42 — trading 61.3% below its estimated fair value. The current Total Liabilities is $569 Mil. Cochlear's overall GF Score™ is 62/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Cochlear (CHEOF), the current Total Liabilities is $569 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cochlear (CHEOF) Overvalued in 2026?

Based on GuruFocus' analysis, Cochlear stock appears to be undervalued. The current stock price of $81.42 is trading 61.3% below its estimated GF Value™ of $210.35. GuruFocus considers Cochlear to be Significantly Undervalued.

Key valuation signals for CHEOF:

  • Total Liabilities: $569 Mil
  • GF Value™: $210.35 vs. price of $81.42 (61.3% below fair value)
  • GF Score™: 62/100 with 2 warning signs

No single metric tells the full story. See the CHEOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cochlear Business Description

Address 1 University Avenue, Macquarie University, Sydney, NSW, AUS, 2109
Cochlear is the leading cochlear implant device manufacturer, with around 60% global market share. Developed markets contribute 80% of group revenue, where cochlear implants are the standard of care for children with severe-to-profound hearing loss. The company also actively targets the growing cohort of seniors in developed markets. Tender-oriented emerging markets contribute the remaining 20% of group revenue. Main products include cochlear implants, bone-anchored hearing aids, and associated sound processors. In fiscal 2025, 49% of revenue came from the Americas, 34% from Europe, the Middle East, and Africa, and 18% from the Asia-Pacific segment.
62GF Score

Get the complete analysis for CHEOF

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$81.42
Price
$210.35
GF Value